Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

Alejandro D. Ricart

doi:10.1158/1078-0432.CCR-11-0486

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

CCR Focus

Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

Alejandro D. Ricart

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-11-0486 Published October 2011

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: October 2011 to January 2021

	Abstract	Full-text HTML	PDF
Total	6898	12068	7968

Cited By

Article Information

Volume 17, Issue 20, pp. 6417-6427

DOI

https://doi.org/10.1158/1078-0432.CCR-11-0486

PubMed

22003069

Published By

American Association for Cancer Research

Print ISSN

1078-0432

Online ISSN

1557-3265

History

Received April 28, 2011
Revision received July 7, 2011
Accepted August 1, 2011
Published first October 14, 2011.

Author Information

Alejandro D. Ricart

Author's Affiliation: Biotechnology Unit and Oncology Clinical Research, Pfizer Inc., San Diego, California

Corresponding Author:
Alejandro D. Ricart, Biotechnology Unit and Oncology Clinical Research, La Jolla Laboratories, Pfizer Inc., 10646 Science Center Drive (CB1), San Diego, CA 92121. Phone: 858-622-7575; Fax: 877-481-3011; E-mail: alejandro.d.ricart{at}pfizer.com

View Full Text

PreviousNext

October 2011
Volume 17, Issue 20

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin